MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    The Genetic and Phenotypic Spectrum of Primary Familial Brain Calcification in a large cohort from China

    ZD. Cen, ZR. Lin, W. Luo (Hangzhou, China)

    Objective: To update the genetic spectrum of primary familial brain calcification (PFBC) and phenotypic characteristics in genetically diagnosed PFBC, and provide genotype-imaging-symptoms correlations of PFBC.…
  • 2025 International Congress

    Heterozygous ATP7B variants in patients with parkinsonism

    T. Liu, Z. Niu, J. Bower, E. Benarroch, O. Ross, L. Malder, R. Savica (Rochester, USA)

    Objective: To describe a retrospective case series of thirteen cases carriers of heterozygous variants of the ATP7B gene manifesting with specific cases of parkinsonism. Background:…
  • 2025 International Congress

    Feasibility of AI-Assisted Screening for Early Parkinson’s in Resource-Limited Settings

    F. Zaier, M. Zribi (Tunis, Tunisia)

    Objective: To evaluate the feasibility of AI-assisted screening for early Parkinson’s disease (PD) in Tunisian primary care. Background: PD poses a growing challenge in Tunisia,…
  • 2025 International Congress

    Patient-Reported Satisfaction and Usability of a Virtual Home-Based Program for Fall Prevention in Parkinson’s Disease

    S. Dharmadhikari, V. Palakuzhy, Y. Kianirad, M. Afshari (Chicago, USA)

    Objective: To evaluate participant perspectives and satisfaction with a virtual home safety intervention to reduce environmental fall risks in persons with Parkinson’s disease (PwPs). Background: While…
  • 2025 International Congress

    Disease Characteristics of the First 100 Participants in the CurePSP Genetics Program Cohort

    C. Obasi, V. Zhao, C. Martinez, S. Scholz, H. Morris, N. Mcfarland, M. Nance, J. Wang, N. Mencacci, B. Cuoto, T. Foroud, J. Verbrugge, A. Miller, L. Heathers, L. Honig, A. Lang, F. Rodriguez-Porcel, P. Moretti, M. Mesaros, J. Brummet, K. Diaz, A. Wills (Boston, USA)

    Objective: To increase our understanding of the pathogenesis of atypical parkinsonian disorders though genetics, and to build a cohort of individuals for future research. Background:…
  • 2025 International Congress

    Exploring The Correlation of Neuroimaging, Molecular and Electrophysiological Biomarkers in Patients with Progressive Supranuclear Palsy – Richardson Type

    S. Mondal, B. Biswas, R. Banerjee, S. Choudhury, K. Chatterjee, J. Rungta, S. Sengupta, A. Bayen, P. Basu, E. Basu, S. Dasgupta, G. Ahmed, J. Ganguly, M. Tiwari, H. Kumar (Kolkata, India)

    Objective: To correlate blood and electrophysiological biomarkers in Progressive Supranuclear Palsy – Richardson’s type (PSP-RS) patients with brain structural alterations using neuromorphometry. Background: Various biomarkers, including…
  • 2025 International Congress

    30-year Delayed Diagnosis of Juvenile Parkinson’s Disease in a Patient Misdiagnosed with Dopa-responsive Dystonia

    N. Mohammed, J. Chen (New Brunswick, USA)

    Objective: To report a case of Juvenile Parkinson’s Disease (JP) misdiagnosed as dopa-responsive dystonia (DRD) and to emphasize the importance of early genetic testing in…
  • 2025 International Congress

    Quantitative Gait Evaluation in Multiple System Atrophy: Supervised versus Unsupervised Analysis

    F. Marchand, J. Labreuche, T. Ollivier, D. Guehl, A. Delval, L. Defebvre, AK. Berger, J. Wiedemann, L. Kjaersgaard, T. Warlop, A. Fasano, BR. Bloem, D. Devos, C. Moreau (Lille, France)

    Objective: This study aims to compare gait parameters in real-world (RW) home settings with supervised clinical assessments on 6-minutes walking test (6MWT) in MSA patients…
  • 2025 International Congress

    Differences Between Clinical and Imaging Phenotypes in Phase 2 Study of ATH434 in Multiple System Atrophy

    P. Trujillo, K. Hett, M. Bradbury, C. Wong, D. Stamler, D. Claassen (Nashville, USA)

    Objective: To assess differences between clinical and imaging phenotypes in Multiple System Atrophy (MSA) and evaluate the reliability of imaging biomarkers for subtype classification. Background:…
  • 2025 International Congress

    Temporal disease patterns prior to Progressive Supranuclear Palsy diagnosis

    M. Fu, T. Chang (Los Angeles, USA)

    Objective: To identify Progressive Supranuclear Palsy (PSP) disease trajectories, defined as the pattern of diagnoses over time, prior to PSP diagnosis in electronic health records.…
  • « Previous Page
  • 1
  • …
  • 107
  • 108
  • 109
  • 110
  • 111
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley